Venmax Drugs And Pharmaceuticals Ltd Share Price & Stock Analysis

Venmax Drugs and Pharmaceuticals Limited engages in the business of pharmaceutical products, drug intermediaries, and API’s. The company was formerly known as Yenkey Drugs & Pharmaceuticals Ltd and changed its name to Venmax Drugs and Pharmaceuticals Limited in April 2009. Venmax Drugs and Pharmaceuticals Limited was incorporated in 1988 and is based in Hyderabad, India.

Key Metrics

Current Price	₹19.32
Market Cap	₹23 Cr
Sector	Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-Industry	Pharmaceuticals > Health Care; Pharmaceuticals, Biotechnology and Life Sciences; Pharmaceuticals; Pharmaceuticals; Pharmaceutical Products
P/E Ratio	92
52-Week Range	₹16.00 – ₹36.96
Beta (1Y)	0.38

Business Segments

1. Pharmaceutical-100%

Peer Companies

• Sanofi Consumer Healthcare India Ltd
• ASTONEA LABS LIMITED
• Bacil Pharma Ltd.
• Goldline Pharmaceutical Limite
• Jfl Life Sciences Limited
• RUBICON RESEARCH LIMITED
• Sunrest Lifescience Limited
• Valiant Laboratories Limited

Frequently Asked Questions

What is the current share price of Venmax Drugs And Pharmaceuticals Ltd?

Venmax Drugs And Pharmaceuticals Ltd is trading at ₹19.32, with a market capitalisation of ₹23 Cr.

Which sector does Venmax Drugs And Pharmaceuticals Ltd belong to?

Venmax Drugs And Pharmaceuticals Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Health Care; Pharmaceuticals, Biotechnology and Life Sciences; Pharmaceuticals; Pharmaceuticals; Pharmaceutical Products).

What are the key financial ratios of Venmax Drugs And Pharmaceuticals Ltd?

Venmax Drugs And Pharmaceuticals Ltd has a P/E of 92.